Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

India & Natco Pharma

4 shared events · Importance 3 · Last updated Mar 31, 2026

Importance
3
Shared Events
4
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
30
Business
India: Lupin (company) and Natco Pharma, both headquartered in India, have expanded their global reach through this U.S. FDA approval.
Natco Pharma: Natco Pharma, in alliance with Lupin (company), secured U.S. FDA approval for its Abbreviated New Drug Application for Eribulin Mesylate Injection, enhancing its oncology portfolio and market presence.
Jun 03, 2026 · 8 articles
0
Business
Natco Pharma: Natco Pharma is one of several Indian companies that launched generic versions of semaglutide, increasing competition for Novo Nordisk.
Mar 30, 2026 · 8 articles
0
Business
Natco Pharma: Natco Pharma is a key player in launching generic semaglutide in India at a significantly lower price, aiming to capture a substantial share of the weight-loss drug market.
Mar 20, 2026 · 8 articles
0
Business
Natco Pharma: Natco Pharma continues to be an investor in Pee Safe.
Mar 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how India and Natco Pharma interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.